ReviewFrontiers in pharmacology2022

Targeting Growth Factor and Cytokine Pathways to Treat Idiopathic Pulmonary Fibrosis.

Hongbo Ma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.